Showing results (1-10 of 3,091) with videos related to
Sort By:
Pageof 310
Antimicrobial Agents and Chemotherapy|May 1, 1989
Comparative pharmacokinetics of clarithromycin (TE-031), a new macrolide antibiotic, and erythromycin in ratsY Kohno, H Yoshida, T Suwa, et al.The Journal of Antimicrobial Chemotherapy|October 1, 1990
Uptake of clarithromycin by rat lung cellsY Kohno, H Yoshida, T Suwa, et al.Antimicrobial Agents and Chemotherapy|April 1, 1990
Autobacteriographic studies of clarithromycin and erythromycin in miceY Kohno, K Ohta, T Suwa, et al.Chirality|January 1, 1996
Stereoselective pharmacokinetics of [14C]-labeled KE-298, a new anti-rheumatic drug, in ratsH Yoshida, Y Kohno, H Endo, et al.Biological & Pharmaceutical Bulletin|January 1, 1997
Relationship between the metabolic chiral inversion and chemical structure of 4-phenyl-4-oxobutanoic acids, derivatives of anti-rheumatic agent KE-298H Yoshida, Y Kohno, H Endo, et al.Biochemical Pharmacology|January 24, 1997
Mechanistic studies on metabolic chiral inversion of 4-(4-methylphenyl)-2-methylthiomethyl-4-oxobutanoic acid (KE-748), an active metabolite of the new anti-rheumatic agent 2-acetylthiomethyl-4-(4-methylphenyl)-4-oxobutanoic acid (KE-298), in ratsH Yoshida, Y Kohno, H Endo, et al.Chirality|January 1, 1997
Stereoselective disposition and chiral inversion of KE-298, a new antirheumatic drug, in ratsH Yoshida, Y Kohno, H Endo, et al.Biological & Pharmaceutical Bulletin|March 1, 1996
Identification of metabolites of KE-298, a new antirheumatic drug, and its physiological properties in ratsH Yoshida, Y Kohno, H Endo, et al.The Journal of Pharmacy and Pharmacology|October 1, 1994
Determination of protein binding of a highly lipophilic drug, isocarbacyclin methyl ester (TEI-9090), using a polydimethylsiloxane-coated glass beads assayT Minagawa, Y Kohno, T Suwa, et al.Biochemical Pharmacology|May 17, 1995
Species differences in hydrolysis of isocarbacyclin methyl ester (TEI-9090) by blood esterasesT Minagawa, Y Kohno, T Suwa, et al.Pageof 310